Literature DB >> 15214504

NMDA receptor function in the prefrontal cortex of a rat model for attention-deficit hyperactivity disorder.

Molupe Lehohla1, Lauriston Kellaway, Vivienne Ann Russell.   

Abstract

The spontaneously hypertensive rat (SHR) is an accepted model for attention-deficit hyperactivity disorder (ADHD) since it displays the major symptoms of ADHD (hyperactivity, impulsivity, and poor performance in tasks that require sustained attention). We have previously shown that glutamate activation of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptors released significantly more norepinephrine from SHR prefrontal cortex slices than control Wistar-Kyoto (WKY) rats. The aim of this study was to determine whether N-methyl-D-aspartate (NMDA) receptor function is disturbed in the prefrontal cortex of SHR. Prefrontal cortex slices were incubated with 45Ca2+ in the presence or absence of 100 microM NMDA for 2 min. Activation of NMDA receptors stimulated significantly less Ca2+ uptake into prefrontal cortex slices of SHR than control WKY (2.8 +/- 0.17 vs. 3.7 +/- 0.38 nmol/mg protein, respectively, P < 0.05). Basal Ca2+ uptake into SHR slices was not significantly different from WKY. These findings are consistent with suggestions that the intracellular concentration of calcium is elevated and therefore the concentration gradient that drives calcium into the cell is decreased in SHR compared to WKY. Impaired NMDA receptor function in the prefrontal cortex of SHR could give rise to impaired cognition and an inability to sustain attention.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15214504     DOI: 10.1023/b:mebr.0000027415.75432.ad

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  31 in total

Review 1.  Is heterosynaptic modulation essential for stabilizing Hebbian plasticity and memory?

Authors:  C H Bailey; M Giustetto; Y Y Huang; R D Hawkins; E R Kandel
Journal:  Nat Rev Neurosci       Date:  2000-10       Impact factor: 34.870

2.  Development of a strain of spontaneously hypertensive rats.

Authors:  K OKAMOTO; K AOKI
Journal:  Jpn Circ J       Date:  1963-03

3.  Renal hemodynamics during development of hypertension in young spontaneously hypertensive rats.

Authors:  Rolf E F Christiansen; Anca B Roald; Olav Tenstad; Bjarne M Iversen
Journal:  Kidney Blood Press Res       Date:  2002       Impact factor: 2.687

4.  Catecholamine modulation of prefrontal cortical cognitive function.

Authors:  A F Arnsten
Journal:  Trends Cogn Sci       Date:  1998-11-01       Impact factor: 20.229

5.  Training of working memory in children with ADHD.

Authors:  Torkel Klingberg; Hans Forssberg; Helena Westerberg
Journal:  J Clin Exp Neuropsychol       Date:  2002-09       Impact factor: 2.475

6.  Enhanced expression of Gi-protein precedes the development of blood pressure in spontaneously hypertensive rats.

Authors:  J Marcil; C Thibault; M B Anand-Srivastava
Journal:  J Mol Cell Cardiol       Date:  1997-03       Impact factor: 5.000

7.  NMDA-stimulated Ca2+ uptake into barrel cortex slices of spontaneously hypertensive rats.

Authors:  M Lehohla; V Russell; L Kellaway
Journal:  Metab Brain Dis       Date:  2001-12       Impact factor: 3.584

8.  Hypertensive brain damage: comparative evaluation of protective effect of treatment with dihydropyridine derivatives in spontaneously hypertensive rats.

Authors:  M Sabbatini; D Tomassoni; F Amenta
Journal:  Mech Ageing Dev       Date:  2001-11       Impact factor: 5.432

9.  Differences between electrically-, ritalin- and D-amphetamine-stimulated release of [3H]dopamine from brain slices suggest impaired vesicular storage of dopamine in an animal model of Attention-Deficit Hyperactivity Disorder.

Authors:  V Russell; A de Villiers; T Sagvolden; M Lamm; J Taljaard
Journal:  Behav Brain Res       Date:  1998-07       Impact factor: 3.332

10.  Altered dopaminergic function in the prefrontal cortex, nucleus accumbens and caudate-putamen of an animal model of attention-deficit hyperactivity disorder--the spontaneously hypertensive rat.

Authors:  V Russell; A de Villiers; T Sagvolden; M Lamm; J Taljaard
Journal:  Brain Res       Date:  1995-04-10       Impact factor: 3.252

View more
  20 in total

1.  Aberrant glutamate signaling in the prefrontal cortex and striatum of the spontaneously hypertensive rat model of attention-deficit/hyperactivity disorder.

Authors:  Erin M Miller; Francois Pomerleau; Peter Huettl; Greg A Gerhardt; Paul E A Glaser
Journal:  Psychopharmacology (Berl)       Date:  2014-02-28       Impact factor: 4.530

2.  Impaired Energy Metabolism and Disturbed Dopamine and Glutamate Signalling in the Striatum and Prefrontal Cortex of the Spontaneously Hypertensive Rat Model of Attention-Deficit Hyperactivity Disorder.

Authors:  Jacqueline J Dimatelis; Jennifer H Hsieh; Toni-Lee Sterley; Lelanie Marais; Jacqueline S Womersley; Maré Vlok; Vivienne A Russell
Journal:  J Mol Neurosci       Date:  2015-02-11       Impact factor: 3.444

3.  Utilizing Focus Groups with Potential Participants and Their Parents: An Approach to Inform Study Design in a Large Clinical Trial.

Authors:  Sandeep Kadimpati; Jennifer B McCormick; Yichen Chiu; Ashley B Parker; Aliya Z Iftikhar; Randall P Flick; David O Warner
Journal:  AJOB Empir Bioeth       Date:  2014-01-01

4.  Persistent hypertension modifies glutamatergic and GABA-ergic synaptic transmission in the rat olfactory brain cortex in vitro.

Authors:  A Kh Khama-Murad; A A Mokrushin
Journal:  Dokl Biol Sci       Date:  2011-01-18

5.  Genetic predisposition and early life experience interact to determine glutamate transporter (GLT1) and solute carrier family 12 member 5 (KCC2) levels in rat hippocampus.

Authors:  Toni-Lee Sterley; Fleur M Howells; Jacqueline J Dimatelis; Vivienne A Russell
Journal:  Metab Brain Dis       Date:  2016-02       Impact factor: 3.584

6.  DNA microarray unravels rapid changes in transcriptome of MK-801 treated rat brain.

Authors:  Yuka Kobayashi; Sofya P Kulikova; Junko Shibato; Randeep Rakwal; Hiroyuki Satoh; Didier Pinault; Yoshinori Masuo
Journal:  World J Biol Chem       Date:  2015-11-26

Review 7.  The role of memantine in the treatment of psychiatric disorders other than the dementias: a review of current preclinical and clinical evidence.

Authors:  Gabriele Sani; Giulia Serra; Giorgio D Kotzalidis; Silvia Romano; Stefano M Tamorri; Giovanni Manfredi; Matteo Caloro; C Ludovica Telesforo; Saverio S Caltagirone; Isabella Panaccione; Alessio Simonetti; Francesca Demontis; Gino Serra; Paolo Girardi
Journal:  CNS Drugs       Date:  2012-08-01       Impact factor: 5.749

8.  Effects of methylphenidate and bupropion on DHEA-S and cortisol plasma levels in attention-deficit hyperactivity disorder.

Authors:  Moon-Soo Lee; Jae-Won Yang; Young-Hoon Ko; Changsu Han; Seung-Hyun Kim; Min-Soo Lee; Sook-Haeng Joe; In-Kwa Jung
Journal:  Child Psychiatry Hum Dev       Date:  2007-08-31

9.  Region-specific alteration in brain glutamate: possible relationship to risk-taking behavior.

Authors:  Bernadette M Cortese; Todd R Mitchell; Matthew P Galloway; Kristen E Prevost; Jidong Fang; Gregory J Moore; Thomas W Uhde
Journal:  Physiol Behav       Date:  2009-12-13

10.  Investigation of post-transcriptional gene regulatory networks associated with autism spectrum disorders by microRNA expression profiling of lymphoblastoid cell lines.

Authors:  Tewarit Sarachana; Rulun Zhou; Guang Chen; Husseini K Manji; Valerie W Hu
Journal:  Genome Med       Date:  2010-04-07       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.